RUNX1 and acute lymphoblastic leukemia: While early studies in childhood ALL reported an incidence below 10%, more contemporary studies consistently demonstrate mutations in 15–30% of ALL cases: more in B lineage disease, a preponderance in hyperdiploidy and a rarity in TEL–AML1 subgroups (10, 15, 16, 19).